跳至主要内容
临床试验/NCT06409546
NCT06409546已完成不适用

Impact of Topical Pentoxifylline and Tocopherol in Treatment and Prevention of Medically-related Osteonecrosis of the Jaws: a Randomized Clinical Trial

University of Catania1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2020年4月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
Oral Health Impact Profile Short Form (OHIP-14)

研究概览

简要总结

While there is no doubt about the benefits of antiresorptives, it is known that patients using these drugs are at increased risk of developing osteonecrosis of the jaws (MRNOJ), especially after oral procedures such as tooth extraction. The management of osteonecrosis has remained a controversial topic within the oral and maxillofacial surgery community.

The aim of the present study is to analyze the impact of topical pentoxifilline and tocopherol in the prevention and treatment of MRNOJ.

详细描述

A double-blind randomized controlled clinical trial is conducted in order to evaluate the impact of topical pentoxifilline and tocopherol in the prevention and treatment of MRNOJ and determine the statistical significance of the outcome variables.

48 subjects with MRNOJ, randomly allocated in two groups: placebo group with a 4% hydroxyethyl cellulose adhesive gel and the treatment group with the same gel containing pentoxifilline 5% and tocopherol 75%.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Sealed envelopes

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Correspondence to the updated SIPMO criteria for MRONJ diagnosis
  • Need for tooth extraction

排除标准

  • Recent use of antibiotics and anti-inflammatories in the last 4 weeks
  • Oral lesions of hard and soft tissues not related to MRONJ

研究组 & 干预措施

Tocopherol 75% and pentoxifilline 5% gel

Active Comparator

Patients treated with a topical gel of tocopherol 75% and pentoxifilline 5%

干预措施: Tocopherol and pentoxifilline topical gel (Drug)

Placebo gel

Placebo Comparator

Patients treated with a topical placebo gel control

干预措施: Placebo (Drug)

结局指标

主要结局

Oral Health Impact Profile Short Form (OHIP-14)

时间窗: 6 months

4-point scale in which the presence or absence of physical pain, functional limitation, psychological distress, physical, psychological and social disability and handicap is analyzed

次要结局

  • Alveolar bone resorption(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gaetano Isola

Researcher

University of Catania

研究点 (1)

Loading locations...

相似试验

Impact of Topical Pentoxifylline and Tocopherol in... | 临床试验